DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Needham Maintains Buy on AtriCure, Raises Price Target to $48

Needham maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $39 to $48.

Benzinga · 01/24/2020 11:18

Needham maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $39 to $48.